Ohm. When you get a chance. Take a look at Aviceda Therapeutics. They are currently working on the eye but their AVD 104 siglec drug claims to alter macrophage microglia differentiation to the less inflammatory and antifibrotic state. Seems like leronlimab has a broader mechanism of action but they are considering looking a liver disease, cancer, neurodegenerative disease as well.